Mississippi Man Diagnosed with Bladder Cancer after Taking Actos, Alleges Lawsuit Filed by Parker Waichman LLP

Share Article

Parker Waichman LLP has filed lawsuit on behalf of a Mississippi man who was diagnosed with bladder cancer, allegedly due to his use of the diabetes drug Actos (pioglitazone). The first Actos Bladder Cancer trial is currently underway in Los Angeles Superior Court.

News Image

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit alleging that Actos caused bladder cancer in a Mississippi man. The suit was filed on April 2, 2013 in the U.S. District Court for the Western District of Louisiana (Case No. 6:13-cv-0684). There, it is one of many pending in the Actos multidistrict litigation known as In Re: Actos (Pioglitazone) Products Liability Litigation (MDL No. 6:11-md-2299). Takeda Pharmaceuticals, America, Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Company have been named as Defendants.

According to the Complaint, the Plaintiff began taking Actos in October 2009 and was diagnosed with bladder cancer in July 2011. The lawsuit alleges that Actos is a defective medication that caused the bladder cancer, and seeks compensation for severe mental and physical pain and suffering, economic loss due to medical expenses and a new lifestyle, and loss of consortium on behalf of the Plaintiff’s wife. The suit alleges that the Defendants were aware of the risks of Actos but made no effort to adequately warn the Plaintiff, his doctor or other users about these dangers.

In 2011, the U.S. Food and Drug Administration (FDA) updated the label on Actos to warn that using the medication for more than a year was associated with an increased risk of bladder cancer. The warning was based on an ongoing 10-year study by Kaiser Permanente. Other studies have continued to support this association. In May 2012, the British Medical Journal (BMJ) published a study showing that patients who took Actos for two years were twice as likely to get bladder cancer. Yet, another study, published in the July 2012, Canadian Medical Association Journal found that Actos use was linked to a 22 percent increased risk of developing bladder cancer.

The first trial over an Actos bladder cancer claim is currently under way in Los Angeles state court; the case is Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court (Los Angeles). The Plaintiff, Jack Cooper, was diagnosed with bladder cancer after taking Actos for four years. According to a March 2013 article in Bloomberg, Cooper alleges that Actos caused his terminal condition and Takeda knew the risks but failed to issue a warning.

Parker Waichman LLP continues to offer free legal consultations to victims of Actos injuries, including bladder cancer, heart problems, and eye injuries. If you or a loved one were diagnosed with bladder cancer after taking Actos, please contact their office by visiting yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Gary Falkowitz
Follow us on
Visit website